Pharmaniaga Bhd. Statistics
Pharmaniaga Bhd. (7081) Stock Statistics & Valuation Metrics
Total Valuation
Pharmaniaga Bhd. has a market cap or net worth of MYR 983.55M. The enterprise value is MYR 2.16B.
- Market Cap
- MYR 983.55M
- Enterprise Value
- MYR 2.16B
Share Statistics
Pharmaniaga Bhd. has 1,311,404,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,311,404,900
- Owned by Insiders
- ―
- Owned by Institutions
- 0.12%
Financial Efficiency
Pharmaniaga Bhd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.59%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 6.59%
- Return on Capital Employed (ROCE)
- 0.20
- Revenue Per Employee
- 1.11M
- Profits Per Employee
- 13.71K
- Employee Count
- 3,538
- Asset Turnover
- 1.75
- Inventory Turnover
- 4.82
Valuation Ratios
The current PE Ratio of Pharmaniaga Bhd. is 12.67. Pharmaniaga Bhd.’s PEG ratio is -0.14.
- PE Ratio
- 12.67
- PS Ratio
- 0.23
- PB Ratio
- 2.10
- Price to FCF
- -6.62
- Price to Operating Cash Flow
- -18.86
- PEG Ratio
- -0.14
Income Statement
In the last 12 months, Pharmaniaga Bhd. had revenue of 3.93B and earned 48.51M in profits. Earnings per share was 0.07.
- Revenue
- 3.93B
- Gross Profit
- 409.16M
- Operating Income
- 129.65M
- Pretax Income
- 74.74M
- Net Income
- 48.51M
- EBITDA
- 168.94M
- Earnings Per Share (EPS)
- 0.07
Cash Flow
In the last 12 months, operating cash flow was -51.10M and capital expenditures -94.56M, giving a free cash flow of -145.66M billion.
- Operating Cash Flow
- -51.10M
- Free Cash Flow
- -145.66M
- Free Cash Flow per Share
- -0.11
Dividends & Yields
Pharmaniaga Bhd. pays an annual dividend of ―, resulting in a dividend yield of 2.35%
- Dividend Per Share
- ―
- Dividend Yield
- 2.35%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.11%
- Earnings Yield
- 6.11%
Stock Price Statistics
- Beta
- 1.85
- 52-Week Price Change
- -43.46%
- 50-Day Moving Average
- 0.97
- 200-Day Moving Average
- 1.18
- Relative Strength Index (RSI)
- 26.16
- Average Volume (3m)
- 2.41M
Important Dates
Pharmaniaga Bhd. upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
Pharmaniaga Bhd. as a current ratio of 0.91, with Debt / Equity ratio of 188.74%
- Current Ratio
- 0.91
- Quick Ratio
- 0.46
- Debt to Market Cap
- 0.80
- Net Debt to EBITDA
- 4.20
- Interest Coverage Ratio
- 2.11
Taxes
In the past 12 months, Pharmaniaga Bhd. has paid 24.05M in taxes.
- Income Tax
- 24.05M
- Effective Tax Rate
- 0.32
Enterprise Valuation
Pharmaniaga Bhd. EV to EBITDA ratio is 9.32, with an EV/FCF ratio of -10.93.
- EV to Sales
- 0.38
- EV to EBITDA
- 9.32
- EV to Free Cash Flow
- -10.93
- EV to Operating Cash Flow
- -31.16
Balance Sheet
Pharmaniaga Bhd. has MYR 152.31M in cash and marketable securities with MYR 780.91M in debt, giving a net cash position of -MYR 628.60M billion.
- Cash & Marketable Securities
- MYR 152.31M
- Total Debt
- MYR 780.91M
- Net Cash
- -MYR 628.60M
- Net Cash Per Share
- -MYR 0.48
- Tangible Book Value Per Share
- MYR 0.25
Margins
Gross margin is 10.15%, with operating margin of 3.11%, and net profit margin of 1.41%.
- Gross Margin
- 10.15%
- Operating Margin
- 3.11%
- Pretax Margin
- 2.07%
- Net Profit Margin
- 1.41%
- EBITDA Margin
- 4.10%
- EBIT Margin
- 3.18%
Analyst Forecast
The average price target for Pharmaniaga Bhd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.75%
- EPS Growth Forecast
- -79.43%
